Vanberra Signal
Free trial

Pulmonescence Diagnostics

Curated by Signal

Developer of novel diagnostic solutions for respiratory diseases

Health Technologypulmondx.com

Overview

Developer of novel diagnostic solutions for respiratory diseases. The company offers REFtb system that uses fluorescence to track, detect, and diagnose infectious agents with sensitivity than existing technologies.

Key facts

Founded
2019
Headquarters
United States
Stage
Sign up to view
Industry
Health Technology

Business model

3 products and services
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • MediCardia Health

    Cardiology-focused EHR platform for clinical workflow

    Health TechnologyMequon, United States

  • GREEN JOURNAL

    Provider of a content platform for cannabis industry news, information, updates, and products

    Health TechnologyOakland, United States

  • Anytime Pediatrics

    Online platform offering telemedicine services for child care

    Health TechnologyNashville, United States

About Pulmonescence Diagnostics

What does Pulmonescence Diagnostics do?

Developer of novel diagnostic solutions for respiratory diseases.

Where is Pulmonescence Diagnostics headquartered?

Pulmonescence Diagnostics is headquartered in United States.

When was Pulmonescence Diagnostics founded?

Pulmonescence Diagnostics was founded in 2019.

Which sector is Pulmonescence Diagnostics in?

Pulmonescence Diagnostics operates in Health Technology.

Who are Pulmonescence Diagnostics's competitors?

Companies similar to Pulmonescence Diagnostics include MediCardia Health, GREEN JOURNAL, and Anytime Pediatrics.